Skip Nav Destination
Issues
15 December 2020
-
Cover Image
Cover Image
Ovarian cancer cells rely on differential signaling of EGFR/ERBB2- or FOXM1-activated pathways when cancer cells become spheroids or when they attach to the mesothelium on distant organs, respectively. Using immunofluorescence, the authors photographed GFP-labeled ovarian cancer cells (green) that were grown on the RFP-labeled mesothelial cells (red). Ovarian cancer cells were then sorted, and gene expression signatures for both adherent and nonadherent cells were determined. The authors further identified that ZEB1 is an important regulator of EGFR, ERBB2, and FOXM1, which are critical for the transition between adherent and nonadherent forms of cells. For details, see the article by Parashar and colleagues on page 5554. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Insights
Reviews
Author Choice
Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis
Min Huang; Joyce O'Shaughnessy; Jing Zhao; Amin Haiderali; Javier Cortés; Scott D. Ramsey; Andrew Briggs; Peter Hu; Vassiliki Karantza; Gursel Aktan; Cynthia Z. Qi; Chenyang Gu; Jipan Xie; Muhan Yuan; John Cook; Michael Untch; Peter Schmid; Peter A. Fasching
Cancer Research Highlights
Genome and Epigenome
Metabolism and Chemical Biology
Author Choice
Endocytosis-Mediated Replenishment of Amino Acids Favors Cancer Cell Proliferation and Survival in Chromophobe Renal Cell Carcinoma
Yi Xiao; Anja Rabien; René Buschow; Vyacheslav Amtislavskiy; Jonas Busch; Ergin Kilic; Sonia L. Villegas; Bernd Timmermann; Moritz Schütte; Thorsten Mielke; Marie-Laure Yaspo; Klaus Jung; David Meierhofer
Molecular Cell Biology
YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis
Stefan Thomann; Sofia M.E. Weiler; Simone Marquard; Fabian Rose; Claudia R. Ball; Marcell Tóth; Teng Wei; Carsten Sticht; Sarah Fritzsche; Stephanie Roessler; Carolina De La Torre; Eduard Ryschich; Olga Ermakova; Carolin Mogler; Daniel Kazdal; Norbert Gretz; Hanno Glimm; Eugen Rempel; Peter Schirmacher; Kai Breuhahn
Tumor Biology and Immunology
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling
Deepak Parashar; Bindu Nair; Anjali Geethadevi; Jasmine George; Ajay Nair; Shirng-Wern Tsaih; Ishaque P. Kadamberi; Gopa Kumar Gopinadhan Nair; Yiling Lu; Ramani Ramchandran; Denise S. Uyar; Janet S. Rader; Prahlad T. Ram; Gordon B. Mills; Sunila Pradeep; Pradeep Chaluvally-Raghavan
Tumor Fibroblast–Derived FGF2 Regulates Expression of SPRY1 in Esophageal Tumor–Infiltrating T Cells and Plays a Role in T-cell Exhaustion
Qing-yun Chen; Yi-ni Li; Xin-yue Wang; Xu Zhang; Yi Hu; Lei Li; Da-qin Suo; Ke Ni; Zhuo Li; Jia-rong Zhan; Ting-ting Zeng; Ying-hui Zhu; Yan Li; Li-jia Ma; Xin-Yuan Guan
Translational Science
Author Choice
Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial
Connie C. Wong; Jason Baum; Angela Silvestro; Michael T. Beste; Bharani Bharani-Dharan; Siyan Xu; Ying A. Wang; Xiaoshan Wang; Margaret F. Prescott; Lynne Krajkovich; Margaret Dugan; Paul M. Ridker; Anne-Marie Martin; Eric C. Svensson
Cancers from Novel Pole-Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint Blockade
Melissa A. Galati; Karl P. Hodel; Miki S. Gams; Sumedha Sudhaman; Taylor Bridge; Walter J. Zahurancik; Nathan A. Ungerleider; Vivian S. Park; Ayse B. Ercan; Lazar Joksimovic; Iram Siddiqui; Robert Siddaway; Melissa Edwards; Richard de Borja; Dana Elshaer; Jiil Chung; Victoria J. Forster; Nuno M. Nunes; Melyssa Aronson; Xia Wang; Jagadeesh Ramdas; Andrea Seeley; Tomasz Sarosiek; Gavin P. Dunn; Jonathan N. Byrd; Oz Mordechai; Carol Durno; Alberto Martin; Adam Shlien; Eric Bouffet; Zucai Suo; James G. Jackson; Cynthia E. Hawkins; Cynthia J. Guidos; Zachary F. Pursell; Uri Tabori
Convergence and Technologies
Author Choice
STAT3-Mediated Astrocyte Reactivity Associated with Brain Metastasis Contributes to Neurovascular Dysfunction
Manuel Sarmiento Soto; James R. Larkin; Chris Martin; Alexandre A. Khrapitchev; Melissa Maczka; Vasiliki Economopoulos; Helen Scott; Carole Escartin; Gilles Bonvento; Sébastien Serres; Nicola R. Sibson
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.